This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
vero cells | 999 |
cell lines | 385 |
infected cells | 280 |
respiratory syndrome | 264 |
acute respiratory | 238 |
severe acute | 219 |
cell line | 214 |
porcine epidemic | 194 |
viral rna | 184 |
epidemic diarrhea | 178 |
antiviral activity | 177 |
cell culture | 169 |
vero cell | 161 |
diarrhea virus | 146 |
virus infection | 140 |
infected vero | 139 |
syndrome coronavirus | 137 |
cell death | 105 |
amino acid | 105 |
infectious bronchitis | 101 |
cell fusion | 101 |
spike protein | 95 |
membrane fusion | 92 |
sars coronavirus | 89 |
zika virus | 89 |
well plates | 87 |
viral replication | 87 |
virus entry | 82 |
virus replication | 82 |
bronchitis virus | 81 |
cells infected | 81 |
dengue virus | 79 |
pedv infection | 79 |
tcid ml | 77 |
cov infection | 75 |
herpes simplex | 75 |
novel coronavirus | 74 |
cdna clone | 74 |
three times | 73 |
plaque assay | 71 |
simplex virus | 70 |
room temperature | 67 |
viral infection | 67 |
epithelial cells | 66 |
zikv infection | 66 |
cell types | 63 |
cytopathic effect | 63 |
mg ml | 62 |
viral entry | 61 |
rna viruses | 61 |
doc id | 61 |
cord uid | 61 |
human coronavirus | 60 |
described previously | 58 |
pedv entry | 58 |
cell monolayers | 58 |
bovine serum | 56 |
virus type | 56 |
recombinant ibvs | 55 |
rna synthesis | 55 |
present study | 53 |
tissue culture | 53 |
african green | 53 |
total rna | 52 |
protein expression | 51 |
time rt | 51 |
signaling pathways | 51 |
virus titers | 51 |
monkey kidney | 50 |
plasma membrane | 50 |
fusion activity | 50 |
western blotting | 50 |
growth kinetics | 49 |
previously described | 49 |
mediated endocytosis | 49 |
chikv ls | 49 |
transmissible gastroenteritis | 49 |
western blot | 49 |
intracellular extracts | 47 |
viral titers | 47 |
crude extract | 47 |
per well | 47 |
green monkey | 47 |
time points | 47 |
protein kinase | 46 |
gene expression | 46 |
viral genome | 46 |
mutant virus | 45 |
gd protein | 45 |
cleavage site | 45 |
cells treated | 45 |
signaling pathway | 45 |
infectious virus | 45 |
days post | 45 |
performed using | 45 |
cell viability | 44 |
fetal bovine | 44 |
cells expressing | 44 |
length cdna | 44 |
viral proteins | 44 |
cultured cells | 44 |
reverse genetics | 43 |
blfp crude | 43 |
post infection | 43 |
wild type | 43 |
washed twice | 43 |
rna polymerase | 43 |
culture supernatants | 42 |
different cell | 42 |
cell cultures | 42 |
infectious clone | 42 |
monoclonal antibody | 42 |
mers pseudovirions | 41 |
negative control | 41 |
pedv strains | 41 |
type i | 41 |
culture medium | 41 |
goat anti | 41 |
virus titer | 40 |
coronavirus infectious | 40 |
chikungunya virus | 40 |
low ph | 40 |
ammonium chloride | 40 |
viral protein | 40 |
host cell | 39 |
united states | 39 |
antiviral effect | 39 |
clinical trials | 39 |
viral titer | 39 |
host cells | 39 |
copies ml | 39 |
ck ch | 38 |
sars patients | 38 |
time point | 38 |
ch ldl | 38 |
amino acids | 38 |
chlamydia pecorum | 38 |
coronavirus infection | 38 |
coronavirus spike | 38 |
hepatitis virus | 38 |
neutralizing antibodies | 38 |
infectious cdna | 37 |
cells well | 37 |
pfu ml | 37 |
influenza virus | 37 |
cell surface | 37 |
fever virus | 37 |
inhibitory effect | 37 |
results showed | 37 |
murine coronavirus | 36 |
determined using | 36 |
cotton rats | 36 |
huh cells | 36 |
gds strains | 35 |
ebola virus | 35 |
sabin poliovirus | 35 |
stranded rna | 35 |
nh cl | 35 |
washed three | 35 |
mouse hepatitis | 35 |
nucleocapsid protein | 35 |
spike glycoprotein | 35 |
cdna clones | 35 |
antiviral activities | 35 |
viral particles | 34 |
structural proteins | 34 |
medium containing | 34 |
control cells | 33 |
cytopathic effects | 33 |
gastroenteritis virus | 33 |
poliovirus type | 33 |
syncytia formation | 33 |
cells transfected | 33 |
neutralizing antibody | 33 |
genomic rna | 33 |
cell entry | 32 |
middle east | 32 |
different concentrations | 32 |
ped virus | 32 |
independent experiments | 32 |
beaudette strain | 32 |
chlamydia abortus | 32 |
replication kinetics | 32 |
also observed | 31 |
viral load | 31 |
expression levels | 31 |
nucleotide sequence | 31 |
previous studies | 31 |
west nile | 31 |
virus isolation | 31 |
results suggest | 31 |
dq cells | 31 |
may also | 30 |
myricetin may | 30 |
life cycle | 30 |
induce apoptosis | 30 |
antiviral drugs | 30 |
body weight | 30 |
copy number | 29 |
genome sequence | 29 |
well plate | 29 |
serially diluted | 29 |
clinical signs | 29 |
trypsin treatment | 29 |
bile acids | 29 |
immune responses | 29 |
mouse igg | 29 |
reverse transcription | 28 |
significantly higher | 28 |
determine whether | 28 |
approved drugs | 28 |
immunofluorescence assay | 28 |
nitric oxide | 28 |
monoclonal antibodies | 28 |
ffu ml | 28 |
three independent | 28 |
culture supernatant | 27 |
sequence analysis | 27 |
vaccine strain | 27 |
previously reported | 27 |
treated cells | 27 |
antiviral agents | 27 |
cov replication | 27 |
time pcr | 27 |
adapted ibv | 27 |
immune response | 27 |
vaccine development | 27 |
east respiratory | 27 |
blot analysis | 27 |
escherichia coli | 26 |
protease inhibitors | 26 |
aurintricarboxylic acid | 26 |
statistically significant | 26 |
nile virus | 26 |
rna levels | 26 |
reverse transcriptase | 26 |
control group | 26 |
mutant viruses | 26 |
syncytium formation | 26 |
coronavirus replication | 26 |
conformational changes | 25 |
produced virus | 25 |
significant difference | 25 |
vitro prophylactic | 25 |
infected mice | 25 |
horseradish peroxidase | 25 |
parental virus | 25 |
results indicated | 25 |
rna interference | 25 |
receptor binding | 25 |
increasing concentrations | 25 |
virus yield | 25 |
induced cell | 25 |
plaque assays | 25 |
open reading | 24 |
virus stock | 24 |
cells via | 24 |
inhibitory activity | 24 |
animal models | 24 |
kidney cells | 24 |
virus adsorption | 24 |
rna replication | 24 |
crystal violet | 24 |
public health | 24 |
chikv infection | 24 |
hela cells | 24 |
synthetic viruses | 24 |
fisher scientific | 23 |
antiviral compounds | 23 |
dynamin ii | 23 |
secondary antibody | 23 |
plaque phenotype | 23 |
helicase protein | 23 |
genbank accession | 23 |
fusion protein | 23 |
conjugated goat | 23 |
virus production | 23 |
virus particles | 23 |
buffered saline | 23 |
log copies | 23 |
infectious diseases | 23 |
thermo fisher | 23 |
induces apoptosis | 23 |
japanese encephalitis | 22 |
cell infection | 22 |
ml streptomycin | 22 |
plate reader | 22 |
measured using | 22 |
taken together | 22 |
porcine nidovirus | 22 |
porcine reproductive | 22 |
fresh medium | 22 |
nucleic acid | 22 |
avian infectious | 22 |
alexa fluor | 22 |
length transcripts | 22 |
enter cells | 22 |
gene mutants | 22 |
innate immune | 22 |
coronavirus associated | 22 |
late endosomes | 22 |
new coronavirus | 22 |
ml penicillin | 22 |
binding site | 22 |
lipid raft | 22 |
pi medium | 22 |
serial dilutions | 21 |
antiviral effects | 21 |
important role | 21 |
rna virus | 21 |
different time | 21 |
toremifene citrate | 21 |
syndrome virus | 21 |
graphpad prism | 21 |
encephalitis virus | 21 |
replication cycle | 21 |
cell monolayer | 21 |
rescued virus | 21 |
gasseri cmul | 21 |
del pedv | 21 |
mdck cells | 21 |
chikv replication | 21 |
inhibitory effects | 21 |
antiviral drug | 21 |
intact pedv | 21 |
ml trypsin | 21 |
virus strain | 21 |
viral shedding | 21 |
viral infections | 20 |
kidney cell | 20 |
invasion rates | 20 |
induced apoptosis | 20 |
mesenteroides ypk | 20 |
iu ml | 20 |
flow cytometry | 20 |
proteolytic cleavage | 20 |
swine fever | 20 |
intracellular viral | 20 |
dependent rna | 20 |
significant differences | 20 |
cell lysates | 20 |
significantly reduced | 20 |
ic values | 20 |
two viruses | 20 |
virus rna | 19 |
applied biosystems | 19 |
authors declare | 19 |
genome sequences | 19 |
virus stocks | 19 |
vaccine candidate | 19 |
primary antibodies | 19 |
vaccinia virus | 19 |
vesicular stomatitis | 19 |
virus strains | 19 |
quantitative rt | 19 |
associated coronavirus | 19 |
avian coronavirus | 19 |
essential medium | 19 |
error bars | 19 |
analyzed using | 19 |
sialic acid | 19 |
viral vaccines | 19 |
viral stock | 19 |
genetics system | 19 |
atcc ccl | 19 |
african swine | 19 |
genome copy | 19 |
pcr analysis | 19 |
electron microscopy | 19 |
activated protein | 18 |
pcr products | 18 |
commercially available | 18 |
kindly provided | 18 |
epidemic diarrhoea | 18 |
spectrum antiviral | 18 |
human immunodeficiency | 18 |
enveloped viruses | 18 |
type iii | 18 |
cells using | 18 |
syncytial virus | 18 |
respiratory syncytial | 18 |
supplementary file | 18 |
vaccine production | 18 |
respiratory tract | 18 |
statistical significance | 18 |
two cell | 18 |
coronavirus disease | 18 |
strand rna | 18 |
treatment group | 18 |
growth medium | 18 |
antisense oligonucleotide | 18 |
rabbit igg | 18 |
hemorrhagic fever | 18 |
sam binding | 18 |
fluorescence microscope | 18 |
i interferon | 18 |
cells grown | 18 |
confluent vero | 18 |
junin virus | 18 |
chlamydial persistence | 17 |
entry process | 17 |
reporter gene | 17 |
mouse monoclonal | 17 |
transcription factor | 17 |
envelope protein | 17 |
cells per | 17 |
tumor cell | 17 |
antiviral efficacy | 17 |
induced cytopathic | 17 |
chlamydia trachomatis | 17 |
weight loss | 17 |
selectivity index | 17 |
recombinant virus | 17 |
target cells | 17 |
sars vaccine | 17 |
subgenomic rna | 17 |
cell spread | 17 |
mouse model | 17 |
widely used | 17 |
lactic acid | 17 |
fold serial | 17 |
distilled water | 17 |
immunodeficiency virus | 17 |
two different | 17 |
infected patients | 17 |
complete genome | 17 |
old pigs | 17 |
signal transduction | 17 |
primary antibody | 17 |
diarrhoea virus | 17 |
endocytic pathway | 17 |
dendritic cells | 17 |
cells exposed | 17 |
infected cell | 16 |
rabbit anti | 16 |
day old | 16 |
early stages | 16 |
untreated cells | 16 |
forming assay | 16 |
infection experiments | 16 |
life technologies | 16 |
lung epithelial | 16 |
polyclonal antibodies | 16 |
ace cells | 16 |
agarose gel | 16 |
plaque size | 16 |
kefir grains | 16 |
binding domain | 16 |
watery diarrhea | 16 |
san diego | 16 |
focus forming | 16 |
host interactions | 16 |
measles virus | 16 |
using vero | 16 |
subgenomic mrnas | 16 |
biosafety level | 16 |
stomatitis virus | 16 |
virus control | 16 |
recent studies | 16 |
standard deviations | 16 |
virus neutralization | 16 |
human cell | 16 |
virus binding | 16 |
consensus sequence | 16 |
respiratory disease | 16 |
growth properties | 16 |
proteolytic processing | 16 |
cell membrane | 16 |
cell cycle | 16 |
plaque reduction | 15 |
positive control | 15 |
expressing cells | 15 |
highly pathogenic | 15 |
per cell | 15 |
passage virus | 15 |
standard deviation | 15 |
porcine aminopeptidase | 15 |
significantly lower | 15 |
vitro antiviral | 15 |
plaque formation | 15 |
containing trypsin | 15 |
viral spike | 15 |
hantavirus replication | 15 |
growth factors | 15 |
egfr pi | 15 |
virus titration | 15 |
serine protease | 15 |
results demonstrate | 15 |
vero jcrb | 15 |
dependent manner | 15 |
virus growth | 15 |
disease virus | 15 |
viral fusion | 15 |
virus produced | 15 |
empty vector | 15 |
point mutation | 15 |
detection limit | 15 |
pfu cell | 15 |
mock group | 15 |
thermofisher scientific | 15 |
subgenomic mrna | 15 |
statistical analysis | 15 |
results suggested | 15 |
reduction assay | 15 |
acidic ph | 15 |
cells showed | 15 |
clinical symptoms | 15 |
mm tris | 15 |
ng ml | 15 |
neutral ph | 15 |
high titers | 15 |
molecular biology | 14 |
related coronavirus | 14 |
protein synthesis | 14 |
mammalian cells | 14 |
virus input | 14 |
polyclonal antibody | 14 |
norway trondheim | 14 |
protease inhibitor | 14 |
fluorescent protein | 14 |
spike proteins | 14 |
accessory proteins | 14 |
pcr assay | 14 |
serine proteases | 14 |
mice infected | 14 |
neutralizing activity | 14 |
yellow fever | 14 |
bars represent | 14 |
rabbit polyclonal | 14 |
persistent infection | 14 |
whole genome | 14 |
positive cells | 14 |
virus infections | 14 |
cytotoxic effect | 14 |
way anova | 14 |
calf serum | 14 |
culture plates | 14 |
insect cells | 14 |
apoptosis via | 14 |
viral envelope | 14 |
endoplasmic reticulum | 14 |
lung cells | 14 |
guinea pigs | 14 |
parental rmv | 14 |
viral antigen | 14 |
hsv infection | 14 |
dmem supplemented | 14 |
transfected cells | 14 |
phylogenetic analysis | 14 |
gds strain | 14 |
intestinal epithelial | 14 |
bat flies | 14 |
pedv strain | 14 |
host factors | 14 |
novel human | 14 |
leukocytic interferon | 14 |
closely related | 13 |
cell survival | 13 |
cells may | 13 |
forming units | 13 |
serum albumin | 13 |
medium alone | 13 |
reverse primer | 13 |
drug repurposing | 13 |
various concentrations | 13 |
quantified using | 13 |
fold dilutions | 13 |
restriction sites | 13 |
infectious disease | 13 |
viral genomic | 13 |
reading frame | 13 |
drug candidates | 13 |
analysis showed | 13 |
bacillus subtilis | 13 |
ifitm cells | 13 |
virus inoculum | 13 |
coronavirus nl | 13 |
peak titer | 13 |
also found | 13 |
mm nh | 13 |
rna transcription | 13 |
small intestine | 13 |
three cell | 13 |
inhibit sars | 13 |
jev production | 13 |
antiviral therapy | 13 |
acid substitutions | 13 |
transcripts containing | 13 |
sindbis virus | 13 |
mouse anti | 13 |
suckling piglets | 13 |
data suggest | 13 |
animal model | 13 |
per ml | 13 |
reading frames | 13 |
cellular rna | 13 |
lm snap | 13 |
genome sequencing | 13 |
small intestinal | 13 |
disease control | 13 |
hong kong | 13 |
virus gd | 13 |
secondary antibodies | 13 |
ibv beaudette | 13 |
visualized using | 13 |
duplex rt | 13 |
severe diarrhea | 13 |
turkey eragem | 13 |
infectious clones | 13 |
pedv icpc | 13 |
pfu well | 13 |
experimental infection | 13 |
growth curves | 13 |
human respiratory | 13 |
mesenteroides subsp | 13 |
endosomal acidification | 12 |
pcr using | 12 |
porcine nidoviruses | 12 |
indicated times | 12 |
blocking buffer | 12 |
human primate | 12 |
cell lineage | 12 |
lg ml | 12 |
human lung | 12 |
vaccine candidates | 12 |
functional receptor | 12 |
monitored daily | 12 |
reference genome | 12 |
akt pathway | 12 |
incubation period | 12 |
endosomal compartments | 12 |
mini kit | 12 |
clinical trial | 12 |
cell tropism | 12 |
culture media | 12 |
previous study | 12 |
also shown | 12 |
sera samples | 12 |
well tissue | 12 |
economic losses | 12 |
neutral red | 12 |
aedes albopictus | 12 |
leader sequence | 12 |
virus propagation | 12 |
hu mutants | 12 |
nonstructural protein | 12 |
like protease | 12 |
real time | 12 |
virus infectivity | 12 |
invasion efficiency | 12 |
final concentration | 12 |
ic value | 12 |
inoculated piglets | 12 |
protein gene | 12 |
nonstructural proteins | 12 |
dmem containing | 12 |
epithelial cell | 12 |
three replicates | 12 |
antisense oligonucleotides | 12 |
vaginal lactobacilli | 12 |
new world | 12 |
linked immunosorbent | 12 |
terminal domain | 12 |
nucleotide sequences | 12 |
dna fragments | 12 |
human cytomegalovirus | 12 |
early endosomes | 12 |
guinea pig | 12 |
lysosomotropic agents | 12 |
media containing | 12 |
also showed | 12 |
enteric coronavirus | 12 |
health organization | 12 |
nns rna | 12 |
reverse genetic | 12 |
gastroenteritis coronavirus | 12 |
graphpad software | 12 |
block hsv | 12 |
cathepsin inhibitors | 12 |
fecal viral | 12 |
high level | 12 |
two independent | 12 |
stat signaling | 12 |
immune cells | 11 |
rna copies | 11 |
ge healthcare | 11 |
dengue activity | 11 |
mem containing | 11 |
world health | 11 |
fda approved | 11 |
inhibitory activities | 11 |
infect vero | 11 |
single infection | 11 |
parental pedvpt | 11 |
live attenuated | 11 |
genomic sequence | 11 |
enzymatic activities | 11 |
cell substrates | 11 |
human airway | 11 |
rna transcripts | 11 |
pedv infected | 11 |
based assay | 11 |
acid binding | 11 |
catalog number | 11 |
molecular docking | 11 |
green fluorescent | 11 |
culture collection | 11 |
mutant transcripts | 11 |
mrna cap | 11 |
rna genome | 11 |
family coronaviridae | 11 |
direct interaction | 11 |
cells overexpressing | 11 |
quality control | 11 |
infectious viral | 11 |
acid bacteria | 11 |
based assays | 11 |
data sets | 11 |
animal experiments | 11 |
whether pedv | 11 |
forward primer | 11 |
also used | 11 |
chlamydial inclusions | 11 |
investigated whether | 11 |
akt signaling | 11 |
virus attachment | 11 |
log pfu | 11 |
high viral | 11 |
ct value | 11 |
week old | 11 |
patients recovered | 11 |
pcr fragments | 11 |
antibody response | 11 |
nd nd | 11 |
results demonstrated | 11 |
vitro transcription | 11 |
primary human | 11 |
antibody titers | 11 |
porcine enteric | 11 |
chlorocebus sabaeus | 11 |
ifitm proteins | 11 |
cell layer | 11 |
commonly used | 11 |
cytotoxic concentration | 11 |
highly conserved | 11 |
cell type | 11 |
cells ml | 11 |
discontinuous transcription | 11 |
pedv isolate | 11 |
recombinant viruses | 11 |
gel electrophoresis | 11 |
national institute | 11 |
prism software | 11 |
clinical use | 11 |
mapk signaling | 11 |
confluent monolayers | 11 |
virus life | 11 |
suckling mice | 11 |
airway epithelial | 11 |
investigate whether | 11 |
future studies | 11 |
binding activity | 11 |
seven recombinant | 11 |
least three | 11 |
spike gene | 11 |
viral progeny | 11 |
viral infectivity | 11 |
supplementary table | 11 |
considered statistically | 11 |
high levels | 11 |
rna extracted | 11 |
dna viruses | 11 |
much lower | 11 |
sterile pbs | 11 |
associated virus | 11 |
fixed concentration | 11 |
specific primers | 11 |
four days | 11 |
acid sequences | 11 |
assay using | 11 |
sequence data | 11 |
epi isl | 11 |
using graphpad | 11 |
minimum essential | 11 |
il i | 11 |
pfu per | 11 |
human ace | 10 |
calculated using | 10 |
acidophilus cmul | 10 |
cells containing | 10 |
viral antigens | 10 |
cfu ml | 10 |
first step | 10 |
apoptosis induced | 10 |
neutralization assay | 10 |
cov spike | 10 |
buffer containing | 10 |
virulent pedvpt | 10 |
virus release | 10 |
data presented | 10 |
minimal essential | 10 |
cellular receptor | 10 |
biological processes | 10 |
prophylactic effects | 10 |
vero ccl | 10 |
cell membranes | 10 |
ms ms | 10 |
conjugated anti | 10 |
immunosorbent assay | 10 |
like particles | 10 |
conformational change | 10 |
extracellular viral | 10 |
free virions | 10 |
interferon alpha | 10 |
genetically stable | 10 |
host immune | 10 |
elevated levels | 10 |
swine enteric | 10 |
sample buffer | 10 |
multiple comparison | 10 |
endosomal pathway | 10 |
interferon production | 10 |
sg mrna | 10 |
kidney epithelial | 10 |
nidovirus replication | 10 |
cellular receptors | 10 |
carrying mutations | 10 |
plantarum cmul | 10 |
significantly inhibited | 10 |
free mem | 10 |
nidovirus infection | 10 |
inhibition assay | 10 |
recombinant human | 10 |
time course | 10 |
coding region | 10 |
ec values | 10 |
peak titers | 10 |
bac cdna | 10 |
egfp reporter | 10 |
cov genome | 10 |
equal volume | 10 |
endosomal membrane | 10 |
acid sequence | 10 |
type culture | 10 |
swine industry | 10 |
serum samples | 10 |
ibv genome | 10 |
chicken embryo | 10 |
genetic stability | 10 |
fold higher | 10 |
comparative analysis | 10 |
growth factor | 10 |
virus vaccine | 10 |
fusion domain | 10 |
natural isolates | 10 |
mm hepes | 10 |
two recombinant | 10 |
without trypsin | 10 |
rna level | 10 |
directed mutagenesis | 10 |
genome landscape | 10 |
dual infections | 10 |
different stages | 10 |
detected using | 10 |
extracted using | 10 |
infectious peritonitis | 10 |
coronavirus nucleocapsid | 10 |
heterogenous hvrs | 10 |
dengue viruses | 10 |
virus isolates | 10 |
bat origin | 10 |
clinical isolate | 10 |
wash buffer | 10 |
cold pbs | 10 |
zikv replication | 10 |
animal care | 10 |
per group | 10 |
embryonated eggs | 10 |
considered significant | 10 |
feline infectious | 10 |
sequence alignment | 10 |
protein induces | 10 |
llcmk cells | 10 |
metabolic activity | 10 |
without blfp | 10 |
concentration ranging | 10 |
side effects | 10 |
american type | 10 |
mixed infections | 10 |
mv vaccine | 10 |
cov rna | 10 |
low toxicity | 10 |
peak viral | 10 |
novel anti | 10 |
asfv infection | 10 |
human cells | 10 |
respiratory distress | 10 |
single amino | 10 |
coronavirus genome | 10 |
adventitious agents | 9 |
expression level | 9 |
cell receptor | 9 |
highly permissive | 9 |
points post | 9 |
mediated entry | 9 |
phosphate broth | 9 |
viruses including | 9 |
penicillin streptomycin | 9 |
washing three | 9 |
downstream targets | 9 |
lymphocytic choriomeningitis | 9 |
cells electroporated | 9 |
host range | 9 |
full genome | 9 |
human betacoronavirus | 9 |
biological functions | 9 |
protein mab | 9 |
day post | 9 |
represent standard | 9 |
virus internalization | 9 |
zikv rna | 9 |
coronavirus receptor | 9 |
three washings | 9 |
emerging viral | 9 |
ebov activity | 9 |
i ifn | 9 |
distress syndrome | 9 |
transferred onto | 9 |
specific mab | 9 |
subgenomic promoter | 9 |
continuous cell | 9 |
maintenance medium | 9 |
coated pit | 9 |
cdna synthesis | 9 |
exogenous proteases | 9 |
thank dr | 9 |
potential antiviral | 9 |
virus assembly | 9 |
gd proteins | 9 |
drug administration | 9 |
dimethyl sulfoxide | 9 |
similar results | 9 |
mrna transcription | 9 |
institutional animal | 9 |
denv replication | 9 |
tryptose phosphate | 9 |
cells stably | 9 |
vitro studies | 9 |
attenuated vaccine | 9 |
acid substitution | 9 |
molecular probes | 9 |
copy numbers | 9 |
early stage | 9 |
significant inhibition | 9 |
progeny yield | 9 |
porcine cell | 9 |
also assessed | 9 |
plaque forming | 9 |
sabin type | 9 |
cellular entry | 9 |
choriomeningitis virus | 9 |
neutralization capacity | 9 |
neutralization test | 9 |
results obtained | 9 |
entire genome | 9 |
accession number | 9 |
viral diseases | 9 |
inhibit viral | 9 |
sense rna | 9 |
ribavirin treatment | 9 |
mammalian cell | 9 |
synthesized transcripts | 9 |
blotting assay | 9 |
virus expressing | 9 |
differentially expressed | 9 |
polyclonal sera | 9 |
log tcid | 9 |
generation sequencing | 9 |
mrna capping | 9 |
co atmosphere | 9 |
luciferase activity | 9 |
human coronaviruses | 9 |
effective concentration | 9 |
swine acute | 9 |
specific antibody | 9 |
mortality rates | 9 |
cells pretreated | 9 |
units ml | 9 |
may interact | 9 |
urgent need | 9 |
envelope glycoprotein | 9 |
type virus | 9 |
indirect immunofluorescence | 9 |
current study | 9 |
data indicate | 9 |
high mortality | 9 |
mtt assay | 9 |
dmem rpmi | 9 |
mg kg | 9 |
blind passages | 9 |
endocytic pathways | 9 |
spinal cord | 9 |
pedv co | 9 |
point mutations | 9 |
supplementary data | 9 |
plate format | 9 |
quantitative real | 9 |
sequencing analysis | 9 |
study demonstrated | 9 |
important roles | 9 |
nafamostat mesylate | 9 |
antigen expression | 9 |
essential role | 9 |
also identified | 9 |
sybr green | 9 |
reduced virus | 9 |
well microplates | 9 |
cells produced | 9 |
hours post | 9 |
converting enzyme | 9 |
res doi | 9 |
length infectious | 9 |
vitro model | 9 |
pcr amplification | 9 |
coronavirus entry | 9 |
confocal microscope | 9 |
group showed | 9 |
viral stocks | 9 |
complete inhibition | 9 |
fusion process | 9 |
also significantly | 9 |
replicated efficiently | 9 |
virus showed | 9 |
throughput screening | 8 |
use committee | 8 |
hsv binding | 8 |
endothelial cells | 8 |
functional characterization | 8 |
suspension cell | 8 |
lethal dose | 8 |
coinfection group | 8 |
new cell | 8 |
ultrastructural changes | 8 |
determined relative | 8 |
dependent endocytosis | 8 |
expression vector | 8 |
infect cells | 8 |
viral loads | 8 |
mediated inhibition | 8 |
significant reduction | 8 |
nelfinavir mesylate | 8 |
cycle threshold | 8 |
may affect | 8 |
recently emerged | 8 |
two replicates | 8 |
screening assay | 8 |
viral rnas | 8 |
free dmem | 8 |
stably expressing | 8 |
entry via | 8 |
significantly decreased | 8 |
studies showed | 8 |
clinical management | 8 |
type specific | 8 |
reporter virus | 8 |
complete protection | 8 |
broome virus | 8 |
rna shedding | 8 |
apoptotic cell | 8 |
proteolytic activation | 8 |
viral spread | 8 |
blotting analysis | 8 |
antiviral response | 8 |
entry inhibitors | 8 |
cell metabolic | 8 |
genome replication | 8 |
inoculated group | 8 |
drug repositioning | 8 |
inoculated onto | 8 |
persistently infected | 8 |
viral life | 8 |
bronchitis coronavirus | 8 |
like proteinase | 8 |
chemical inhibitors | 8 |
head syndrome | 8 |
plasmid pcdna | 8 |
control wells | 8 |
peritonitis virus | 8 |
information processing | 8 |
fecal consistency | 8 |
cells cultured | 8 |
mediated antiviral | 8 |
enteric alphacoronavirus | 8 |
stock virus | 8 |
confocal microscopy | 8 |
methyl cellulose | 8 |
virus envelope | 8 |
swollen head | 8 |
potent antiviral | 8 |
viral pathogenesis | 8 |
first time | 8 |
mock infected | 8 |
using lipofectamine | 8 |
lines tested | 8 |
assay showed | 8 |
viral pathogens | 8 |
transcribed rna | 8 |
porcine deltacoronavirus | 8 |
like cleavage | 8 |
noncoding rna | 8 |
pedv rna | 8 |
second transfection | 8 |
dendritic cell | 8 |
science foundation | 8 |
virus glycoprotein | 8 |
respiratory coronavirus | 8 |
chikv strains | 8 |
direct virucidal | 8 |
cell proliferation | 8 |
french polynesia | 8 |
tissue tropism | 8 |
using trizol | 8 |
mediated membrane | 8 |
using anti | 8 |
international committee | 8 |
virus genome | 8 |
dominant negative | 8 |
previous reports | 8 |
specific monoclonal | 8 |
culture flask | 8 |
plos one | 8 |
optical density | 8 |
new variants | 8 |
traditional chinese | 8 |
results confirmed | 8 |
cycle progression | 8 |
infectious sars | 8 |
coronavirus infections | 8 |
cleavage products | 8 |
rubella virus | 8 |
containing fbs | 8 |
susceptible cell | 8 |
incubated overnight | 8 |
likely due | 8 |
study showed | 8 |
different treatment | 8 |
total number | 8 |
clinically approved | 8 |
transcription mechanism | 8 |
also demonstrated | 8 |
type ii | 8 |
mutant rzikv | 8 |
rhvr i | 8 |
one day | 8 |
pcr kit | 8 |
various time | 8 |
infected monolayers | 8 |
hydrogen bond | 8 |
mediated endocytic | 8 |
representative experiment | 8 |
antiviral research | 8 |
equal amounts | 8 |
developmental cycle | 8 |
borne encephalitis | 8 |
mutation frequency | 8 |
subgenomic rnas | 8 |
forming unit | 8 |
co incubator | 8 |
polymerase chain | 8 |
asterisks indicate | 8 |
ribosomal rna | 8 |
clinical studies | 8 |
anova followed | 8 |
fusion proteins | 8 |
lysis buffer | 8 |
st cells | 8 |
clinical samples | 8 |
isolate knu | 8 |
various types | 8 |
molecular characterization | 8 |
blood samples | 8 |
serum concentration | 8 |
regulated deps | 8 |
master mix | 8 |
antiviral ability | 8 |
sus scrofa | 8 |
treated vero | 8 |
light microscopy | 8 |
class i | 8 |
leuconostoc mesenteroides | 8 |
without myricetin | 8 |
ebov mak | 8 |
treatment groups | 8 |
lipid rafts | 8 |
serial passages | 8 |
nucleotide substitutions | 8 |
sialic acids | 8 |
pedv infectivity | 8 |
reverse primers | 8 |
inverted microscope | 8 |
chlamydial infection | 8 |
transcripts generated | 8 |
fresh vero | 8 |
effective antiviral | 8 |
vitro transcribed | 8 |
induce cell | 8 |
five fragments | 8 |
cellular membranes | 8 |
hsv gd | 8 |
curve analysis | 8 |
cells date | 8 |
growth performance | 8 |
coronavirus ibv | 8 |
cysteine protease | 8 |
kda protein | 7 |
probably due | 7 |
dengue infection | 7 |
us strains | 7 |
continuous treatment | 7 |
chikv rna | 7 |
fluorescent focus | 7 |
hematopoietic cell | 7 |
infectious particles | 7 |
highest concentration | 7 |
transcription factors | 7 |
conjugated secondary | 7 |
orally inoculated | 7 |
terminal region | 7 |
described elsewhere | 7 |
several coronaviruses | 7 |
pcr system | 7 |
infected groups | 7 |
myricetin treatment | 7 |
first case | 7 |
treatment stage | 7 |
treated virus | 7 |
animal cells | 7 |
fruit bats | 7 |
bhk cells | 7 |
transmission electron | 7 |
immune system | 7 |
dna fragmentation | 7 |
inhibits zika | 7 |
baboon orthoreovirus | 7 |
tissue sections | 7 |
wide range | 7 |
endocytosis pathway | 7 |
data analysis | 7 |
statistical analyses | 7 |
wt sequence | 7 |
neutralization tests | 7 |
like particle | 7 |
rpoa gene | 7 |
response curve | 7 |
inhibit cell | 7 |
high virus | 7 |
purified using | 7 |
effectively inhibit | 7 |
bac clone | 7 |
five days | 7 |
data indicated | 7 |
antibody responses | 7 |
biological properties | 7 |
step rt | 7 |
induced cpe | 7 |
better understanding | 7 |
mapk activation | 7 |
mortality rate | 7 |
sequencing reads | 7 |
virus isolate | 7 |
membrane protein | 7 |
cells compared | 7 |
different types | 7 |
analysis revealed | 7 |
human hepatoma | 7 |
standard error | 7 |
detection kit | 7 |
similar kinetics | 7 |
recent study | 7 |
technical assistance | 7 |
cells also | 7 |
mm nacl | 7 |
chemical synthesis | 7 |
production processes | 7 |
may cause | 7 |
mm edta | 7 |
therapeutic strategies | 7 |
protein production | 7 |
graph pad | 7 |
accession numbers | 7 |
bars indicate | 7 |
response curves | 7 |
first reported | 7 |
outer capsid | 7 |
additional file | 7 |
virus present | 7 |
cloning strategy | 7 |
course analysis | 7 |
vehicle control | 7 |
agarose gels | 7 |
induced membrane | 7 |
hsv entry | 7 |
matrix protein | 7 |
passage number | 7 |
novel therapeutic | 7 |
research center | 7 |
broad spectrum | 7 |
viral foci | 7 |
synthesized full | 7 |
available antiviral | 7 |
virus penetration | 7 |
generated using | 7 |
similar growth | 7 |
acid position | 7 |
internalized pedv | 7 |
cell nucleus | 7 |
via endocytosis | 7 |
negative strand | 7 |
chain reaction | 7 |
inhibitory concentration | 7 |
may block | 7 |
rna mini | 7 |
days two | 7 |
see supplementary | 7 |
second passage | 7 |
extracellular supernatants | 7 |
viral activity | 7 |
bacterial cells | 7 |
chicken eggs | 7 |
much smaller | 7 |
transmembrane serine | 7 |
jev plaque | 7 |
hela cell | 7 |
step growth | 7 |
bei resources | 7 |
qiaamp viral | 7 |
using two | 7 |
capsid protein | 7 |
coronavirus hku | 7 |
associated protein | 7 |
acid identity | 7 |
rna copy | 7 |
nuclear factor | 7 |
cell adhesion | 7 |
reduction assays | 7 |
virus particle | 7 |
competing interests | 7 |
newcastle disease | 7 |
free medium | 7 |
indian ocean | 7 |
pedv isolation | 7 |
citrate buffer | 7 |
recombinant mv | 7 |
immunofluorescent staining | 7 |
sars pseudovirions | 7 |
heptad repeat | 7 |
zikv group | 7 |
southern china | 7 |
protease tmprss | 7 |
lopinavir ritonavir | 7 |
fluorescence intensity | 7 |
infectious dose | 7 |
cultured vero | 7 |
avian influenza | 7 |
genital herpes | 7 |
gene sequences | 7 |
assay conditions | 7 |
many viruses | 7 |
factor receptor | 7 |
loading control | 7 |
subsequently incubated | 7 |
virus activity | 7 |
pcr results | 7 |
passaged virus | 7 |
binding assay | 7 |
igg antibody | 7 |
via clathrin | 7 |
mean values | 7 |
one representative | 7 |
ibv strains | 7 |
tissue samples | 7 |
isolated virus | 7 |
perinuclear region | 7 |
virus spike | 7 |
effective vaccines | 7 |
terminal amino | 7 |
structural protein | 7 |
fecal pedv | 7 |
method described | 7 |
map kinase | 7 |
later time | 7 |
culture model | 7 |
adhesion molecule | 7 |
small molecule | 7 |
semliki forest | 7 |
trypsin inhibitor | 7 |
chloroquine treatment | 7 |
recognizes residues | 7 |
quasispecies diversity | 7 |
research community | 7 |
fold diluted | 7 |
primer sequences | 7 |
mouth disease | 7 |
genus alphacoronavirus | 7 |
cellular proteins | 7 |
viral quasispecies | 7 |
also inhibited | 7 |
culture infective | 7 |
korean pedv | 7 |
forest virus | 7 |
binding protein | 7 |
influenza viruses | 7 |
bronchial epithelial | 7 |
line vero | 7 |
jcrb cells | 7 |
fusion activities | 7 |
virus ns | 7 |
may lead | 7 |
entry step | 7 |
rna production | 7 |
ifn treatment | 7 |
natural isolate | 7 |
viral genomes | 7 |
one hour | 7 |
well clusters | 7 |
dependent kinase | 7 |
gene copies | 7 |
also confirmed | 7 |
sanofi pasteur | 7 |
susceptible cells | 7 |
overlay medium | 7 |
eagle medium | 7 |
emerging viruses | 7 |
virus passage | 7 |
scale bars | 7 |
genomic characterization | 7 |
chloroquine derivatives | 7 |
old spf | 7 |
one doi | 7 |
data obtained | 7 |
pathway groups | 7 |
permissive cell | 7 |
emerging coronaviruses | 7 |
bac approach | 7 |
severe disease | 7 |
isg genes | 7 |
experimental conditions | 7 |
trypsin cleavage | 7 |
diploid cell | 7 |
order nidovirales | 7 |
infected tissues | 7 |
severe covid | 7 |
hydrogen peroxide | 7 |
oxide synthase | 7 |
microbiol doi | 7 |
female balb | 7 |
cdna fragments | 7 |
etiological agent | 7 |
several studies | 7 |
rhesus macaque | 7 |
host response | 7 |
following infection | 7 |
also known | 7 |
template dna | 7 |
viral membrane | 7 |
primer pairs | 7 |
pigs infected | 7 |
egfp expression | 7 |
plasmids encoding | 7 |
pedv activity | 7 |
structural basis | 7 |
transcription kit | 7 |
australia vic | 6 |
rabies virus | 6 |
ion channels | 6 |
inhibitory action | 6 |
derived cell | 6 |
relatedness values | 6 |
two times | 6 |
marburg virus | 6 |
compared using | 6 |
culture infectious | 6 |
serine proteolysis | 6 |
like coronavirus | 6 |
cycle arrest | 6 |
group coronaviruses | 6 |
bacterial expression | 6 |
inclusion size | 6 |
yield inhibition | 6 |
efficient replication | 6 |
syncytial cells | 6 |
also determined | 6 |
four different | 6 |
see also | 6 |
mediated fusion | 6 |
probiotic bacteria | 6 |
protein may | 6 |
highly contagious | 6 |
intestinal contents | 6 |
genes involved | 6 |
kg ton | 6 |
gn piglets | 6 |
neutralization assays | 6 |
chronic hepatitis | 6 |
foetal calf | 6 |
gene ontology | 6 |
paulo city | 6 |
means control | 6 |
dodecyl sulfate | 6 |
drug concentrations | 6 |
south korea | 6 |
muench method | 6 |
glass coverslips | 6 |
deleted region | 6 |
internalization assay | 6 |
chlorogenic acid | 6 |
infected host | 6 |
comparison tests | 6 |
sequence comparison | 6 |
studies will | 6 |
kg cells | 6 |
sequencing data | 6 |
crystal structure | 6 |
higher virus | 6 |
time reverse | 6 |
serially passaged | 6 |
using specific | 6 |
performed according | 6 |
phage display | 6 |
virol doi | 6 |
three different | 6 |
plaque sizes | 6 |
ypk possessed | 6 |
horseshoe bats | 6 |
left panel | 6 |
inclusions consisting | 6 |
cr vi | 6 |
polyacrylamide gel | 6 |
currently available | 6 |
coronavirus mhv | 6 |
viral binding | 6 |
cho cells | 6 |
homozygous deletion | 6 |
hcv infection | 6 |
abc kit | 6 |
virus disease | 6 |
using primers | 6 |
heavy chain | 6 |
well culture | 6 |
protein samples | 6 |
antiviral strategies | 6 |
jcrb cell | 6 |
mrna levels | 6 |
human papillomavirus | 6 |
highly virulent | 6 |
new porcine | 6 |
inoculated pigs | 6 |
blood cell | 6 |
log ffu | 6 |
passaged sabin | 6 |
previous findings | 6 |
rneasy mini | 6 |
block viral | 6 |
mesylate hydrate | 6 |
genome segments | 6 |
showed higher | 6 |
direct fusion | 6 |
relative cell | 6 |
fusing activity | 6 |
flavivirus infection | 6 |
plaque purification | 6 |
much less | 6 |
bacterial artificial | 6 |
grand island | 6 |
nitrocellulose membrane | 6 |
vitro using | 6 |
relatively low | 6 |
daily gain | 6 |
coronavirus oc | 6 |
binding sites | 6 |
viable cells | 6 |
repeat region | 6 |
virus fusion | 6 |
diluted virus | 6 |
rna helicase | 6 |
pedv may | 6 |
single infections | 6 |
infected pigs | 6 |
seed virus | 6 |
arg residue | 6 |
main proteinase | 6 |
reduced viral | 6 |
fluorescent assay | 6 |
first transfection | 6 |
randomly assigned | 6 |
observational study | 6 |
mm chloroquine | 6 |
receptor protein | 6 |
pedv invasion | 6 |
coinfection groups | 6 |
establishing persistent | 6 |
capsid layer | 6 |
first passages | 6 |
recombinant rmv | 6 |
including sars | 6 |
infectious viruses | 6 |
unless otherwise | 6 |
cellular proteases | 6 |
porcine transmissible | 6 |
therapeutic drugs | 6 |
sucrose cushion | 6 |
state university | 6 |
related viruses | 6 |
light microscope | 6 |
fecal shedding | 6 |
yfv plaques | 6 |
infective dose | 6 |
confirmed covid | 6 |
higher levels | 6 |
standard curve | 6 |
signal transducer | 6 |
chlamydia pneumoniae | 6 |
onto fresh | 6 |
pedv enters | 6 |
serial dilution | 6 |
parental rzikv | 6 |
positive controls | 6 |
protective efficacy | 6 |
convalescent sera | 6 |
jev infection | 6 |
feed additive | 6 |
fusion peptide | 6 |
phosphate buffered | 6 |
cellular processes | 6 |
pedv particles | 6 |
existing drugs | 6 |
selected passages | 6 |
days later | 6 |
pedv activities | 6 |
viral control | 6 |
higher cell | 6 |
pfu pig | 6 |
software version | 6 |
repurposing library | 6 |
significant antiviral | 6 |
kda polypeptide | 6 |
results indicate | 6 |
newborn piglets | 6 |
minor variants | 6 |
mouse secondary | 6 |
nucleotide changes | 6 |
mild diarrhea | 6 |
may play | 6 |
previous results | 6 |
coronavirus rna | 6 |
dependent pathway | 6 |
linear fit | 6 |
fold reduction | 6 |
pcr product | 6 |
infection model | 6 |
plasma igg | 6 |
undefined functions | 6 |
gene sequence | 6 |
antibody titer | 6 |
short reads | 6 |
puerto rico | 6 |
human leukocyte | 6 |
grey lines | 6 |
immunostaining using | 6 |
lab isolates | 6 |
phase ii | 6 |
parental vaccine | 6 |
without fbs | 6 |
stimulated genes | 6 |
viral plaques | 6 |
apoptosis induction | 6 |
indicated time | 6 |
prophylactic effect | 6 |
results confirm | 6 |
dengue hemorrhagic | 6 |
neonatal piglets | 6 |
viral inhibition | 6 |
spot number | 6 |
common cold | 6 |
biorxiv doi | 6 |
ring finger | 6 |
primers used | 6 |
gastrointestinal tract | 6 |
immunofluorescence microscopy | 6 |
gut microbiota | 6 |
pedv blfp | 6 |
causative agent | 6 |
cells without | 6 |
fecal samples | 6 |
human cd | 6 |
epidermal growth | 6 |
later stages | 6 |
fusogenic orthoreovirus | 6 |
saudi arabia | 6 |
negative mutant | 6 |
small interfering | 6 |
thermo scientific | 6 |
north america | 6 |
inhibit hsv | 6 |
detect viral | 6 |
invasion rate | 6 |
medium supplemented | 6 |
conducted using | 6 |
average daily | 6 |
cov receptor | 6 |
blocking solution | 6 |
cercopithecus aethiops | 6 |
pedv infections | 6 |
molecular mechanisms | 6 |
using human | 6 |
replicase polyproteins | 6 |
biogenic amines | 6 |
ace expression | 6 |
soybean trypsin | 6 |
well known | 6 |
vitro models | 6 |
neutralization titer | 6 |
recently reported | 6 |
virus yields | 6 |
two fragments | 6 |
synergistic effect | 6 |
therapeutic agents | 6 |
antibody conjugated | 6 |
regulated kinase | 6 |
progeny virus | 6 |
indicated concentrations | 6 |
experiments performed | 6 |
red lines | 6 |
limb paralysis | 6 |
natural host | 6 |
sequence identity | 6 |
variable response | 6 |
entry assay | 6 |
vaccine design | 6 |
first passage | 6 |
viral titration | 6 |
five times | 6 |
prevent zikv | 6 |
strongly inhibited | 6 |
determined whether | 6 |
organismal systems | 6 |
breast cancer | 6 |
orf gene | 6 |
nested set | 6 |
field strains | 6 |
viral mrna | 6 |
ifitm expression | 6 |
akt proteins | 6 |
foci formation | 6 |
right panel | 6 |
initiate internalization | 6 |
old world | 6 |
early infection | 6 |
fluorescence microscopy | 6 |
human diploid | 6 |
hu carrying | 6 |
high degree | 6 |
necrosis factor | 6 |
entry mechanism | 6 |
sb cells | 6 |
possessed anti | 6 |
effective anti | 6 |
neighboring cells | 6 |
rgn infectious | 6 |
infected animals | 6 |
many studies | 6 |
pretreated cells | 6 |
polyclonal serum | 6 |
experimentally infected | 6 |
ifa assay | 6 |
two groups | 6 |
zikv strains | 6 |
approved drug | 6 |
mm ammonium | 6 |
inhibiting sars | 6 |
artificial chromosome | 6 |
replication properties | 6 |
phylogenetic analyses | 6 |
species transmission | 6 |
van dinten | 6 |
stimulated gene | 6 |
attenuated vaccines | 6 |
entry pathway | 6 |
virology doi | 6 |
actin reorganization | 6 |
conserved among | 6 |
cpe reduction | 6 |
total cellular | 6 |
cm tissue | 6 |
genetic diversity | 6 |
ongoing clinical | 6 |
intraperitoneal therapy | 6 |
hsv infected | 6 |
endogenous ifitm | 6 |
blocks cell | 6 |
del pedvs | 6 |
previously shown | 6 |
swine pedv | 6 |
pedv specific | 6 |
ebov infection | 6 |
rabbit antiserum | 6 |
reactive oxygen | 6 |
derived virus | 6 |
cells together | 6 |
qpcr using | 6 |
ph environment | 6 |
infection media | 6 |
negative mutants | 6 |
resistant viruses | 6 |
lymph nodes | 6 |
chlamydial developmental | 6 |
internalized virus | 6 |
green monkeys | 6 |
highly expressed | 6 |
ctrl means | 6 |
cytokine chemokine | 6 |
old female | 6 |
variant strains | 6 |
species severe | 6 |
enveloped virus | 6 |
differ significantly | 6 |
pedv polyclonal | 6 |
genome size | 6 |
particle associated | 6 |
severe clinical | 6 |
disease caused | 6 |
embryonated chicken | 6 |
cells three | 6 |
natural science | 6 |
cov proteins | 6 |
assigned values | 6 |
covinfected cells | 6 |
coding sequence | 6 |
hind limb | 6 |
cut fragment | 6 |
three hvrs | 6 |
clinical isolates | 6 |
late stage | 6 |
also tested | 6 |
significantly different | 6 |
glo assay | 6 |
may help | 6 |
potent inhibitor | 6 |
respiratory illness | 6 |
human metapneumovirus | 6 |
peripheral blood | 6 |
effective vaccine | 6 |
positive serum | 6 |
genome organization | 6 |
previous report | 6 |
new insights | 6 |
zinc binding | 6 |
health concern | 6 |
animal species | 6 |
induced cytotoxicity | 5 |
clinical manifestations | 5 |
lung tissue | 5 |
cpe inhibition | 5 |
entry followed | 5 |
antiviral defense | 5 |
transcription complexes | 5 |
dose dependent | 5 |
higher concentrations | 5 |
orthoreovirus genus | 5 |
good candidate | 5 |
unique restriction | 5 |
i ii | 5 |
scale bar | 5 |
therapeutic potential | 5 |
membrane permeability | 5 |
used cell | 5 |
nonessential amino | 5 |
transduction pathways | 5 |
log rna | 5 |
incubation times | 5 |
target cell | 5 |
test compared | 5 |
gastric adenocarcinoma | 5 |
bl mice | 5 |
tne buffer | 5 |
using different | 5 |
additional mutations | 5 |
two interferons | 5 |
significant increase | 5 |
blast analysis | 5 |
potential anti | 5 |
internalized virions | 5 |
experimental groups | 5 |
acid changes | 5 |
poultry industry | 5 |
multiple sequence | 5 |
hl cells | 5 |
innate antiviral | 5 |
loaded onto | 5 |
ibv rna | 5 |
using spss | 5 |
lab species | 5 |
shedding titers | 5 |
wide variety | 5 |
specific viral | 5 |
reverse transcribed | 5 |
developing countries | 5 |
primate cells | 5 |
derived vero | 5 |
five female | 5 |
polybasic cleavage | 5 |
cotton rat | 5 |
central nervous | 5 |
aberrant chlamydial | 5 |
amplified using | 5 |
massively parallel | 5 |
two piglets | 5 |
ml per | 5 |
cm flask | 5 |
type infection | 5 |
pedv inoculation | 5 |
genes coding | 5 |
viral glycoproteins | 5 |
length genome | 5 |
glass slides | 5 |
additional files | 5 |
contact piglets | 5 |
cancer cell | 5 |
infected piglets | 5 |
pedv positive | 5 |
sodium hypochlorite | 5 |
reduces viral | 5 |
also probed | 5 |
vectastain abc | 5 |
cell genome | 5 |
limited number | 5 |
universal type | 5 |
induces membrane | 5 |
entry occurs | 5 |
pure chemical | 5 |
overlapping dna | 5 |
aberrant bodies | 5 |
full protection | 5 |
world bats | 5 |
displayed peptides | 5 |
infectious rna | 5 |
regulatory factor | 5 |
national taiwan | 5 |
successful isolation | 5 |
neutralizing mabs | 5 |
pedv spike | 5 |
phosphorothioate protection | 5 |
virus detection | 5 |
approved antiviral | 5 |
production process | 5 |
modified eagle | 5 |
isolate pedv | 5 |
pcr reactions | 5 |
protective immunity | 5 |
cell supernatants | 5 |
infectious titer | 5 |
intranasal interferon | 5 |
active compounds | 5 |
internalization rates | 5 |
treated control | 5 |
read alignment | 5 |
bovine viral | 5 |
genetic assembly | 5 |
assays indicated | 5 |
delta virus | 5 |
mediated death | 5 |
cells incubated | 5 |
mrna species | 5 |
relatively high | 5 |
england biolabs | 5 |
infection might | 5 |
biomedical sciences | 5 |
bsl facilities | 5 |
nitrogen intermediates | 5 |
entry depends | 5 |
deduced amino | 5 |
dual infection | 5 |
lower viral | 5 |
units per | 5 |
economic loss | 5 |
treated group | 5 |
completely inhibited | 5 |
fermented products | 5 |
three blind | 5 |
content imaging | 5 |
coronavirus sars | 5 |
human use | 5 |
large deletion | 5 |
new england | 5 |
two types | 5 |
genomic sequences | 5 |
plates seeded | 5 |
cancer cells | 5 |
mm dtt | 5 |
generated two | 5 |
terminal kinase | 5 |
mouse antibody | 5 |
analysis indicated | 5 |
interfering rna | 5 |
reduce viral | 5 |
late endosome | 5 |
fold lower | 5 |
cells induces | 5 |
acid extraction | 5 |
us porcine | 5 |
low levels | 5 |
calculated based | 5 |
incubation time | 5 |
celisa results | 5 |
specific antibodies | 5 |
biological replicates | 5 |
lab strains | 5 |
sample collection | 5 |
bacterial intracellular | 5 |
induced syncytia | 5 |
vitro inhibition | 5 |
less infectious | 5 |
binding stage | 5 |
rna sequence | 5 |
mast cells | 5 |
higher neutralizing | 5 |
buffered formalin | 5 |
cholesterol accumulation | 5 |
nm harringtonine | 5 |
nucleoside analogues | 5 |
exhibited anti | 5 |
ngs reads | 5 |
inactivated virus | 5 |
mediated virus | 5 |
gii subtype | 5 |
persistent infections | 5 |
vivo studies | 5 |
gene synthesis | 5 |
log reduction | 5 |
inhibits influenza | 5 |
two mutant | 5 |
naturally infected | 5 |
rousettus aegyptiacus | 5 |
nakayama strain | 5 |
viral particle | 5 |
national key | 5 |
aligned using | 5 |
acute diarrhea | 5 |
antiviral potential | 5 |
sequence alignments | 5 |
persistent sars | 5 |
viability assay | 5 |
phase i | 5 |
antiviral immune | 5 |
productive infection | 5 |
washing twice | 5 |
infectious center | 5 |
enzymes involved | 5 |
hu strain | 5 |
infected individuals | 5 |
protein cleavage | 5 |
days old | 5 |
south american | 5 |
fetal calf | 5 |
cause respiratory | 5 |
polyclonal nsp | 5 |
maximum likelihood | 5 |
tumor cells | 5 |
antibody staining | 5 |
specific neutralizing | 5 |
mycophenolic acid | 5 |
viruses enter | 5 |
rational design | 5 |
observed within | 5 |
quantitative pcr | 5 |
viral material | 5 |
maximal inhibitory | 5 |
mv mutants | 5 |
blood mononuclear | 5 |
molecular function | 5 |
experimentally inoculated | 5 |
lentiviruses pseudotyped | 5 |
specific igg | 5 |
chemically synthesized | 5 |
genetic marker | 5 |
infection induces | 5 |
hsv effects | 5 |
virus inhibition | 5 |
stably cloned | 5 |
adsorption assay | 5 |
myricetin possessed | 5 |
jansen van | 5 |
four times | 5 |
potential inhibitors | 5 |
emerging virus | 5 |
protect cells | 5 |
novel orthoreovirus | 5 |
neuraminidase inhibitors | 5 |
van vuren | 5 |
cells appeared | 5 |
betacov australia | 5 |
immune evasion | 5 |
infectious titers | 5 |
similar manner | 5 |
inactivated poliovirus | 5 |
piglets supplemented | 5 |
mammalian orthoreovirus | 5 |
published sequence | 5 |
human population | 5 |
inhibited sars | 5 |
cpz treatment | 5 |
recombinant coronavirus | 5 |
vitro assembly | 5 |
results clearly | 5 |
cov virus | 5 |
concurrent treatment | 5 |
overlapping fragments | 5 |
amersham biosciences | 5 |
phase progression | 5 |
viral effects | 5 |
ml ifn | 5 |
core sequence | 5 |
vaccine platform | 5 |
interferon response | 5 |
mosquito cells | 5 |
cov diluted | 5 |
pegylated interferon | 5 |
quantitative proteomics | 5 |
mrna synthesis | 5 |
restriction site | 5 |
cultured overnight | 5 |
cell passage | 5 |
inhibited virus | 5 |
inactivated vaccine | 5 |
quasispecies population | 5 |
cells seeded | 5 |
national research | 5 |
phase clinical | 5 |
new species | 5 |
imaging system | 5 |
cov may | 5 |
furin cleavage | 5 |
broad range | 5 |
mumps virus | 5 |
hantavirus infection | 5 |
studies using | 5 |
cap analog | 5 |
seven sars | 5 |
crucial role | 5 |
formation assay | 5 |
specific pathogen | 5 |
chlamydia psittaci | 5 |
prepared using | 5 |
yeast extract | 5 |
cellular transcription | 5 |
human health | 5 |
mv challenge | 5 |
pfu ratio | 5 |
complete genomic | 5 |
side effect | 5 |
cov activity | 5 |
relative gene | 5 |
initial screening | 5 |
activator protein | 5 |
viral susceptibility | 5 |
pigs inoculated | 5 |
like receptor | 5 |
peptide concentrations | 5 |
one experiment | 5 |
internal reference | 5 |
primary chicken | 5 |
charged amino | 5 |
chloroquine effectively | 5 |
protein bands | 5 |
spectrum antivirals | 5 |
virucidal activity | 5 |
new virus | 5 |
sequence encoding | 5 |
rna isolated | 5 |
chlamydial infections | 5 |
cells yielded | 5 |
lassa virus | 5 |
cytotoxic dose | 5 |
human disease | 5 |
cell lysis | 5 |
leukocyte interferon | 5 |
drug combinations | 5 |
significantly increased | 5 |
salivary iga | 5 |
inverted light | 5 |
restriction factors | 5 |
nucleotide position | 5 |
clearly showed | 5 |
growth characteristics | 5 |
assembly system | 5 |
sodium dodecyl | 5 |
acid region | 5 |
low level | 5 |
fusion core | 5 |
findings suggest | 5 |
rgn strain | 5 |
respiratory viruses | 5 |
post inoculation | 5 |
support viral | 5 |
high concentrations | 5 |
initial infection | 5 |
obtained using | 5 |
cell banks | 5 |
clone using | 5 |
vector laboratories | 5 |
isolate nl | 5 |
intracellular replication | 5 |
ihc staining | 5 |
interferon subtypes | 5 |
antiviral genes | 5 |
mean spot | 5 |
human pathogen | 5 |
overlay media | 5 |
ncrna generation | 5 |
bush viper | 5 |
host proteins | 5 |
receptor ace | 5 |
lm sin | 5 |
induce fusion | 5 |
independent clones | 5 |
susceptible vero | 5 |
membrane vesicles | 5 |
mmessage mmachine | 5 |
particular ic | 5 |
bat species | 5 |
cleavage motif | 5 |
aberrant inclusions | 5 |
recombinant ibv | 5 |
pad prism | 5 |
gradually increased | 5 |
endocytic vesicles | 5 |
cl pro | 5 |
gradient centrifugation | 5 |
groups treated | 5 |
apoptotic cells | 5 |
another study | 5 |
flaviviridae family | 5 |
environmental information | 5 |
pig farms | 5 |
kinase inhibitors | 5 |
vaccine preparations | 5 |
may provide | 5 |
free media | 5 |
human pulmonary | 5 |
mediated enhancement | 5 |
different species | 5 |
proven protease | 5 |
mouse sera | 5 |
influence ebola | 5 |
provide valuable | 5 |
clinically proven | 5 |
big plaques | 5 |
combined therapies | 5 |
among others | 5 |
vitro ligation | 5 |
viper reovirus | 5 |
hamster cell | 5 |
glycogen synthase | 5 |
mononuclear cells | 5 |
randomly chosen | 5 |
chikv activity | 5 |
vitro inhibitory | 5 |
platelets activation | 5 |
cell damage | 5 |
microtiter plates | 5 |
rescued viruses | 5 |
humoral response | 5 |
murine leukemia | 5 |
cell lysate | 5 |
nervous system | 5 |
measuring viral | 5 |
histopathological examination | 5 |
diarrhea syndrome | 5 |
recombinant strains | 5 |
cov vaccine | 5 |
protein ns | 5 |
virus spread | 5 |
serotype strain | 5 |
systematic review | 5 |
time intervals | 5 |
prb pathway | 5 |
antiviral screening | 5 |
induce phosphorylation | 5 |
focus assay | 5 |
ped outbreaks | 5 |
recombinant seacov | 5 |
plaque purified | 5 |
may facilitate | 5 |
cellular egfr | 5 |
humoral immune | 5 |
negative controls | 5 |
genus flavivirus | 5 |
block sars | 5 |
inhibited entry | 5 |
inhibit zikv | 5 |
coronavirus induces | 5 |
cellular lysates | 5 |
cytotoxic effects | 5 |
porcine intestinal | 5 |
viral suspension | 5 |
slightly lower | 5 |
seacov infectious | 5 |
gene pulser | 5 |
hepatitis delta | 5 |
double infected | 5 |
functions within | 5 |
identify novel | 5 |
mature virions | 5 |
endosomal compartment | 5 |
pbs containing | 5 |
ibv strain | 5 |
viruses produced | 5 |
two washes | 5 |
surface glycoproteins | 5 |
functional information | 5 |
sequencing kit | 5 |
fluorescent cells | 5 |
order genetic | 5 |
confocal fluorescence | 5 |
next generation | 5 |
pedv degs | 5 |
transcription using | 5 |
kbp cdnas | 5 |
pcr assays | 5 |
pedv replication | 5 |
two isolates | 5 |
orf ab | 5 |
parallel sequencing | 5 |
ebola antiviral | 5 |
inactivated fetal | 5 |
least one | 5 |
adapter sequences | 5 |
ultrathin sections | 5 |
several different | 5 |
oral administration | 5 |
tumor necrosis | 5 |
four post | 5 |
entry receptor | 5 |
mediated cell | 5 |
viral release | 5 |
ac pab | 5 |
spf chickens | 5 |
duplicated subgenomic | 5 |
rna samples | 5 |
reporter plasmid | 5 |
oxygen atom | 5 |
virus induced | 5 |
si value | 5 |
successful entry | 5 |
will provide | 5 |
violet staining | 5 |
taiwan university | 5 |
flavivirus production | 5 |
medical center | 5 |
viral gene | 5 |
sized plaques | 5 |
mucosal immunity | 5 |
many different | 5 |
bat coronavirus | 5 |
human monoclonal | 5 |
normal control | 5 |
well microtiter | 5 |
entry mediated | 5 |
pneumonia outbreak | 5 |
potential antivirals | 5 |
hu vaccine | 5 |
large polymerase | 5 |
plaque morphology | 5 |
severe respiratory | 5 |
high titer | 5 |
associated proteins | 5 |
two decades | 5 |
two plasmids | 5 |
transcriptase inhibitors | 5 |
without gentamycin | 5 |
emerged novel | 5 |
zikv infectious | 5 |
standard curves | 5 |
cellular protein | 5 |
intracellular rna | 5 |
cell receptors | 5 |
spot size | 5 |
synthase kinase | 5 |
chikv cdna | 5 |
left indicate | 5 |
morphological changes | 5 |
internal control | 5 |
readily detected | 5 |
qpcr targeting | 5 |
high throughput | 5 |
inactivated fbs | 5 |
first patient | 5 |
length sequence | 5 |
sgrna encoding | 5 |
antigen level | 5 |
critical role | 5 |
leukemia virus | 5 |
experiments using | 5 |
drug screen | 5 |
virus date | 5 |
hsv replication | 5 |
blfp group | 5 |
origin cov | 4 |
coronavirus mouse | 4 |
infected control | 4 |
known coronaviruses | 4 |
acid ph | 4 |
clostridium perfringens | 4 |
changed every | 4 |
may occur | 4 |
encephalitis reporter | 4 |
xlog ffu | 4 |
small intestines | 4 |
replicative cycle | 4 |
fatal case | 4 |
antivirals tested | 4 |
accessory protein | 4 |
conserved core | 4 |
nearby clusters | 4 |
specific primary | 4 |
fluorescein isothiocyanate | 4 |
cause severe | 4 |
innate immunity | 4 |
medically important | 4 |
antiviral mechanism | 4 |
type ifn | 4 |
dbt cells | 4 |
coli strains | 4 |
antibodies used | 4 |
genetic systems | 4 |
containing myricetin | 4 |
chikungunya viruses | 4 |
cap methylation | 4 |
encode nonessential | 4 |
first report | 4 |
cell nuclei | 4 |
molecular targets | 4 |
body junction | 4 |
virus surface | 4 |
chikv genomes | 4 |
also evaluated | 4 |
particles associated | 4 |
randomised placebo | 4 |
cellular protease | 4 |
borne flaviviruses | 4 |
host translation | 4 |
examined using | 4 |
proteomic analysis | 4 |
large intestine | 4 |
similar ic | 4 |
containing mm | 4 |
dna fragment | 4 |
genome expression | 4 |
zikv ns | 4 |
efficacious vaccines | 4 |
three washes | 4 |
reciprocal serum | 4 |
bacillus licheniformis | 4 |
maximal cytotoxic | 4 |
developing new | 4 |
six drugs | 4 |
pit assembly | 4 |
induces phosphorylation | 4 |
mhv infection | 4 |
zoster virus | 4 |
five pigs | 4 |
allowed us | 4 |
dna synthesis | 4 |
human tumor | 4 |
trypsin activity | 4 |
containing tcid | 4 |
great economic | 4 |
existing chikv | 4 |
intestinal tissues | 4 |
constitutive activation | 4 |
protein similar | 4 |
pedv isolates | 4 |
inoculated vero | 4 |
endocytic marker | 4 |
viral receptors | 4 |
culture system | 4 |
effective inhibitor | 4 |
viral cores | 4 |
outbreak associated | 4 |
cecum tonsils | 4 |
low toxic | 4 |
corresponding fragments | 4 |
original feces | 4 |
gd mrna | 4 |
sensor chip | 4 |
surface receptors | 4 |
different steps | 4 |
south africa | 4 |
glycosylation sites | 4 |
ml sbti | 4 |